StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

The trailer shows off a first look at some of the cards, as well as card battle gameplay screenshots. We also get a look at some characters arriving in the app, including Kanata Hondo, Futre, and ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results, is ...

The Telangana Assembly on March 18 passed a Bill for the sub-categorisation of Scheduled Castes (SCs) for fair distribution of reservation as per the order passed by the Supreme Court last year.

AYANEO announced its first Android gaming tablet along with a more traditional handheld console – these are the first devices to be powered by the new Snapdragon G3 Gen 3. The company describes ...

Devices that bring streaming powers to your old hi-fi kit aren't new, but this new device aims to bring the most popular streaming elements to existing products without being tied to any single brand ...

AYANEO has announced two new gaming devices with the latest Snapdragon G3 Gen 3 processor. The Pocket S2 is a refresh of its flagship handheld, and the Gaming Pad is the company’s first tablet.

While the overall implant failure rate was relatively low (5.67% over two years), understanding these risk factors is essential for both patients and clinicians to optimize treatment success.